Abstract
Our skin provides a physical and immunological barrier against dehydration and environmental insults ranging from microbial attacks, toxins and UV irradiation to wounding. Proper functioning of the skin barrier largely depends on the interplay between keratinocytes- the epithelial cells of the skin- and immune cells. Two spatially distinct populations of keratinocyte stem cells (SCs) maintain the epidermal barrier function and the hair follicle. These SCs are inherently long-lived, but cell death can occur within their niches and impacts their functionality. The default cell death programme in skin is apoptosis, an orderly and non-inflammatory suicide programme. However, recent findings are shedding light on the significance of various modes of regulated necrotic cell death, which are lytic and can provoke inflammation within the local skin environment. While the presence of dying cells was generally regarded as a mere consequence of inflammation, findings in various human dermatological conditions and experimental mouse models of aberrant cell death control demonstrated that cell death programmes in keratinocytes (KCs) can drive skin inflammation and even tumour initiation. When cells die, they need to be removed by phagocytosis and KCs can function as non-professional phagocytes of apoptotic cells with important implications for their SC capacities. It is becoming apparent that in conditions of heightened SC activity, distinct cell death modalities differentially impact the different skin SC populations in their local niches. Here, we describe how regulated cell death modalities functionally affect epidermal SC niches along with their relevance to injury repair, inflammatory skin disorders and cancer.
Similar content being viewed by others
Facts
-
Cell death is a central element in healthy mammalian skin and regulates hair cycling
-
Distinct types of regulated cell death differentially alter the various stem cell niches present in skin
-
Dysregulated cell death pathways in keratinocytes drive skin inflammation and carcinogenesis
-
Keratinocyte stem cells can act as occasional phagocytes by clearing dead/dying cells
Outstanding Questions
-
Which factors define the differential sensitivity of distinct skin stem cells to cell death?
-
Is there a role for non-apoptotic cell death programmes in hair cycling regulation?
-
Can we manipulate cell death responses to improve cutaneous wound healing, while preventing tumorigenesis?
-
What is the therapeutic potential of manipulating cell death switches in the skin?
The epidermis as a structural and immunological barrier
Skin comprises an epidermal layer, consisting of keratinocytes (KCs) and various immune cell-types including innate immune cells such as Langerhans cells and macrophages, but also adaptive memory T-cells and cells considered to bridge innate and adaptive immunity, namely γδ T-cells. Underneath the epidermal layer, the skin’s dermis is mainly populated by fibroblasts, adipocytes and endothelial cells [1]. KCs form the structure of the epidermis and its appendages, including hair follicles (HFs), sweat glands and sebaceous glands [2]. KCs located in the interfollicular epidermis maintain the permeability barrier of the skin, crucial to sustain the hydration levels of the body. This barrier is formed by differentiating KCs originating from the keratinocyte stem and progenitor cells, which are located in the basal layer -the lower layer of the epidermis where cells are attached to the basement membrane. Asymmetric SC divisions in this basal layer lead to the detachment of one of the daughter cells from this membrane, which results in the gradual differentiation of KCs to form a cornified layer protecting the skin from excessive water loss, UVB irradiation and pathogen entry [3]. This terminal differentiation process is also termed ‘cornification’ and is tightly orchestrated as reviewed elsewhere [4]. KCs, dermal fibroblasts and resident immune cells can release various cytokines, chemokines, danger-associated molecular patterns (DAMPs) and antimicrobial peptides to evoke an appropriate immune response upon skin challenge [1]. These molecules will bind their cognate receptors leading to the production of more inflammatory mediators and cytoprotective factors, thereby fighting off infections, while assisting in the maintenance of the skin barrier function. This intercellular crosstalk between KCs, fibroblasts and immune cells is crucial to mediate skin function, not only in homeostasis, but also in injury repair and other inflammatory conditions [1, 5].
Distinct skin stem cell niches exhibit different sensitivities to cell death
As a tissue with a remarkably high epithelial turnover rate, skin depends on a delicate balance between cell proliferation, differentiation, senescence and death. To provide for the specific proliferative needs of each epidermal compartment, mammalian skin contains different SC populations that are spatially separated in distinct niches [2]. These niches are not merely physical locations harbouring SCs, but refer to the microenvironment where intrinsic and extrinsic signals, including those emanating from dying/dead cells, converge to determine SC fates. Keratinocyte SCs residing in the basal layer of the interfollicular epidermis, termed epidermal stem cells (EpdSCs), proliferate to give rise to KCs that can differentiate into corneocytes and thereby maintain the barrier function of the skin [2]. Cell death is normally absent in the various layers of homeostatic interfollicular epidermis [6], indicating robust pro-survival mechanisms that facilitate the entry of KCs into the differentiation process and ensure successful completion of barrier formation (Fig. 1). Indeed, genetic mouse models have elucidated that aberrant cell death in the EpdSC niche often results in barrier perturbation and subsequent inflammation [7,8,9,10] (Table 1). A second population of keratinocyte SCs is located in the hair follicle (HF). These hair follicle stem cells (HFSCs) can be discriminated in mouse skin based on specific marker gene expression, such as Lgr5, Cd34 and Sox9 [11]. HFSCs also depend on their attachment to the basement membrane to maintain stemness, and undergo a specialized differentiation programme to ensure HF maintenance during the various stages of the hair cycle [12,13,14]. The spatially distinct niche where HFSCs reside is known as the bulge (Fig. 1). In contrast to the EpdSC niche, this tissue compartment experiences periodic bouts of substantial cell death during hair cycle regression (Box 1). In between EpdSCs and HFSCs, a region known as the junctional zone, LRIG1+ keratinocyte SCs are present and give rise to the murine sebaceous gland. A subpopulation of these SCs expresses GATA6, a marker for the sebaceous duct [15, 16]. The distinct populations of keratinocyte SCs are spatially and functionally separated in homeostatic skin conditions. However, during injury repair and in neoplastic conditions, several HFSCs are mobilized to regions where they normally do not reside to exert functions that differ from their homeostatic roles, a phenomenon that is termed SC plasticity [17,18,19].
Hair cycling is characterized by a growth phase of the HF (anagen), followed by a regression phase (catagen) mediated by excessive keratinocyte death, and a subsequent resting phase (telogen) [20] (Box 1). Growth of the HF is induced by reciprocal interactions between HFSCs and fibroblasts located in the dermal papilla, a specialized structure at the base of the HF [2, 21]. After growth, the length of the HF drastically reduces in the late stages of catagen, a process mediated by cell death and contraction of the dermal sheath, composed of smooth muscle cells wrapping the HF [20, 22]. Despite the extensive cell death that occurs in catagen, this physiological process is not accompanied by a pronounced inflammatory response. This implicates apoptosis, as a non-lytic cell death modality, as a major cell death programme in catagen [20]. Indeed, elegant intravital imaging studies demonstrated a spatial gradient of apoptotic basal KCs during the regression stage of the HF [23]. Signalling downstream of tumour necrosis factor-receptor-1 (TNFR1), a crucial decision point between pro-inflammatory signalling or cell death induction, has been implicated in hair cycling [24,25,26]. Not only is the death of KCs essential for regulating hair cycling, but apoptotic macrophages expressing TREM2 also influence HFSC proliferation (Box 1) [27]. Clearly, the distinct SC niches present in skin are confronted with varying rates of cell death, to which they respond differentially in order to maintain their specific tissue compartments.
Other SC populations present in the skin of most mammals include melanocyte stem cells (MeSCs) responsible for skin pigmentation, and sweat gland SCs [2, 28]. While limited information exists on the role of different cell death programmes in melanocyte and sweat gland biology, the death of melanocytes is associated with the common pigmentation disorder vitiligo. Moreover, genome-wide association studies (GWAS) have identified variations in genes involved in the executioner phase of apoptosis as susceptibility factors for vitiligo [29]. Here, we focus on examining the impact of cell death on keratinocyte SC niches in homeostasis and during injury repair and tumour formation, as recent advances highlight the crucial role played by various cell death programmes and their control mechanisms in preserving skin function in these conditions.
Regulated cell death in the skin
Regulated cell death was long considered synonymous to apoptosis, but different types of molecularly controlled cell death pathways, including necroptosis, pyroptosis and ferroptosis, have now been described and implicated in the maintenance of skin immune homeostasis [7, 30,31,32]. Apoptosis is mediated by upstream initiator caspases (caspase-8 and -9), which activate downstream effector caspases (caspase-3, -6 and -7) responsible for executing the apoptotic process. This process is typically non-immunogenic due to the formation of apoptotic bodies that are phagocytosed by neighbouring cells [23]. Indeed, efficient removal of these cell corpses, a process termed efferocytosis, will prohibit the induction of a pronounced immune response [33]. Conversely, necroptosis and pyroptosis are lytic types of cell death that generate pores in the plasma membrane leading to the release of the intracellular content, including cytokines and DAMPs, in the extracellular environment. This induces a strong inflammatory response (Fig. 2) [34, 35]. Lytic cell death can potently drive skin inflammation, but upon certain challenges KCs can opt to undergo senescence, a cellular programme that is also capable of instigating inflammatory responses (Reviewed in [36]). The relative contribution of these two biological processes to dermatitis remains to be determined, but will likely depend on the nature of the inflammatory trigger.
Necroptosis is induced in conditions of deregulated apoptotic signalling, upon triggering of death receptors, type 1 interferon receptor, specific Toll-like receptors or infections with pathogens [37,38,39,40,41]. This type of programmed death relies on the activation of receptor interacting protein kinase 3 (RIPK3) and subsequent phosphorylation of mixed-lineage kinase domain-like protein (MLKL), resulting in MLKL translocation to the plasma membrane, subsequent pore formation and cell lysis [42]. Dysregulated apoptotic signalling can lead to sensitization of KCs to necroptosis and proper control of necroptosis in this cell-type is crucial to prevent dermatitis [7, 8]. Pyroptosis is another form of lytic cell death, usually caused by microbial infection, that relies on the proteolytic activation of gasdermin-D (GSDMD) by caspase-1 and caspase-11 or caspase-8, thereby unleashing GSDMD’s pore-forming activity [43]. Next to MLKL and GSDMD facilitating pore formation in different cell death types, plasma membrane rupture is further accomplished by NINJURIN-1 [44]. Activation of caspase-1 occurs in inflammasome complexes that are assembled after triggering of specific NOD-like receptors (NLRs), AIM2 (absent in melanoma 2) or pyrin. These receptors recognize various microbial insults or other stressors including extracellular ATP and uric acid crystals [45]. Cells dying by pyroptosis release bioactive IL-1β and IL-18, two cytokines that potently alter skin immunity. Increasing evidence suggests that inflammasome complexes play a crucial role in mediating skin immune surveillance [29, 30, 46]. Other forms of cell death have been described more recently in the context of cutaneous pathology, including ferroptosis, NETosis, autophagy-induced cell death, cuproptosis and panoptosis [47,48,49]. These cell death programmes will only be briefly discussed here, as their roles in skin homeostasis and inflammation are largely enigmatic.
Apoptosis and necroptosis
Apoptosis was the first type of cell death shown to be regulated by specific genetic programmes [50]. This cell death modality regulates important developmental processes and is crucial for tissue homeostasis [51, 52]. Although apoptotic cells can release compounds that affect tissue functioning [53], apoptosis is generally considered immune silent. However, an excessive amount of apoptosis can lead to secondary necrosis and subsequent inflammation [54, 55]. In homeostatic skin conditions, apoptotic caspases are not activated in the EpdSC niche [6]. Conversely, a marked abundance of apoptosis is induced in the HFSC niche during catagen, the regression stage of the hair cycle (Box 1). These cyclic bouts of cell death eliminate a substantial number of KCs and melanocytes in the HFSC niche, without provoking significant inflammation. This phenomenon thus offers a unique model for studying how tissue physiology is maintained in the presence of abundant cell death.
Apoptosis is induced by two different pathways, depending on the origin of the trigger (Fig. 2). The intrinsic pathway to apoptosis occurs upon dysregulation of intracellular homeostasis caused by toxic triggers or DNA damage, and involves BAX/BAK-induced mitochondrial pore formation and cytochrome c release from the mitochondria [56]. This induces the formation of the apoptosome and activation of caspase-9 [57]. In conditions of DNA damage triggering intrinsic apoptosis, the longevity of HFSCs is regulated by overexpression of the anti-apoptotic protein BCL-2 [58]. Upregulation of this protein in mouse KCs leads to abnormal HFSC niche architecture, evidenced by the enlarged bulge area that develops over time in these mice [59]. In agreement, depletion of the pro-apoptotic protein BAX in HFs results in HFSC niche expansion [60]. The extrinsic apoptotic pathway is triggered by cell death stimuli of the TNF superfamily, including TNF, Fas ligand (FASL) and TNF-related apoptosis-inducing ligand (TRAIL) that bind to their cognate receptors on the plasma membrane. Binding of TNF to TNFR1 results in the induction of a pro-inflammatory signalling cascade leading to nuclear factor-kappa B (NF-κB) activation and survival, or in the formation of a death-inducing complex. The decision between these paradoxical outcomes depends on the assembly of specific multi-protein complexes [61] (Fig. 3). Formation of complex I involves the recruitment of TRADD and RIPK1 to TNFR1, allowing the subsequent assembly of TRAF2/5, cIAP1/2 and the Linear Ubiquitination Chain Assembly Complex (LUBAC), activating a downstream signalling cascade leading to NF-κB and MAPK activation, induction of pro-inflammatory signalling and survival. The ubiquitin network associated with complex I is negatively regulated by A20, CYLD and OTULIN, which destabilize the signalling complex and attenuate signalling to MAPKs and NF-κB [61]. In a pro-survival context, caspase-8 can cleave RIPK1 thereby limiting apoptotic and necroptotic cell death [62]. However, TNF can also induce cell death via the assembly of a secondary cytosolic complex, termed complex II, which originates from the binding of FAS-associated death domain-containing protein (FADD) to the receptor-dissociated complex I components TRADD and/or RIPK1. This complex now functions as a platform for binding and activation of caspase-8 triggering apoptotic or pyroptotic cell death, depending on the cellular context [63, 64]. In the absence of caspase-8 activation, a different complex termed the necrosome can be assembled, involving RIPK1 and RIPK3, which drives necroptosis. The significance of precisely controlling the formation of TNF-induced complexes in KCs is evident from the severe inflammatory skin phenotypes that arise after depletion of the proteins constituting these complexes or the checkpoints regulating their activity in mouse KCs [65,66,67,68,69,70,71,72,73] (Table 1). Additionally, several human skin pathologies are associated with variations in genes responsible for assembling TNF-induced complexes [74].
Genetic ablation of key apoptotic mediators, such as caspase-8, FADD and RIPK1, in mouse KCs triggers KC necroptosis and severe skin inflammation [7,8,9,10] (Table 1). The induction of necroptosis in KCs initiates a feed forward cycle of inflammation, subsequent epidermal barrier permeability and skin demise, explaining the perinatal or early postnatal lethality associated with these genotypes. Mice lacking caspase-8 selectively in KCs exhibit hyperplasia of the basal and spinous layers, expression of keratin-6 (K6) in the interfollicular epidermis, enhanced cell death rates in the epidermis and marked infiltration of specific subsets of immune cells in both epidermis and dermis [9, 10]. The epidermis of skin with FADD-deficient KCs shows similar defects [8]. Likewise, mice lacking RIPK1 in KCs exhibit epidermal thickening, reduced K10 expression and abundant presence of apoptotic and necroptotic cells in their epidermis. Ablation of RIPK3 in these KC-selective RIPK1-deficient mice averts skin inflammation, indicating the high potency of necroptosis in driving dermatitis [7]. RIPK1 prevents KC necroptosis in a kinase-independent manner by binding to RIPK3 via RIP homotypic interaction motif (RHIM) domains. Absence of the RIPK1 RHIM domain in KCs leads to spontaneous Z-DNA-binding protein 1 (ZBP1)-dependent necroptosis, severe skin inflammation and perinatal lethality. Indeed, RIPK1 RHIM is essential to prevent ZBP1 from binding and activating RIPK3 and subsequent MLKL phosporylation [75,76,77]. Interestingly, when mice with these highly inflamed skin phenotypes due to absence of apoptotic genes are born, inflammation seems to be increased from postnatal day 5 onwards, coinciding with the initiation of the first round of anagen [8, 78, 79]. It is therefore tempting to speculate that the altered activation state of the HFSCs contributes to the inflammatory phenotypes observed in these mice.
Whether KCs die by apoptosis or necroptosis has pivotal implications for skin function. Whitin the TNFR-pathway, various key decision points that switch the cell death programme from apoptosis to necroptosis have been identified [61] (Fig. 3). One of these control mechanisms is ubiquitination, a post-translational modification in which chains of ubiquitin (Ubq) molecules are attached on substrates. This process is mediated by ubiquitin E3 ligases and reversed by deubiquitinases (DUBs) [80]. These Ubq chains are linked by lysine residues present in Ubq or by its N-terminal methionine residue (therefore also termed M1 chains) and have important scaffolding functions for the assembly of the pro-inflammatory complex 1 upon TNF triggering [81]. Linear Ubq chains are attached to their substrates by the E3 ligase complex LUBAC consisting of HOIL-1 (heme-oxidized IRP2 ubiquitin ligase 1), HOIP (HOIL-1 interacting protein) and SHARPIN (Shank-associated RH-domain interacting protein), and are removed by the DUBs CYLD (cylindromatosis) and OTULIN (OTU deubiquitinase with linear linkage specificity) [82,83,84]. While CYLD can remove both K63 and M1 Ubq chains, OTULIN has exclusive affinity for M1 Ubq chains [83, 85]. Interestingly, genetic deletion of single LUBAC components or of the DUBs that can remove M1 chains, selectively in KCs, results in severe inflammatory skin phenotypes caused by excessive KC death [78, 79, 86, 87] (Table 1). While deletion of HOIP and HOIL-1 in KCs results in massive skin inflammation and early postnatal lethality, which is delayed upon compound removal of TNF or TNFR1 [79], the phenotypes of mice lacking functional SHARPIN or keratinocyte-selective OTULIN are respectively milder or fully rescued upon removal of TNFR1 [78, 84, 87, 88], indicating that different molecular mechanisms regulate KC lethality in these distinct genetic contexts. Importantly, patients carrying loss-of-function mutations in the OTULIN gene suffer from ORAS (OTULIN-related autoinflammatory syndrome), a severe and often lethal autoinflammatory syndrome affecting multiple organs including skin. ORAS patients present with skin lesions reminiscent of nodular panniculitis with neutrophil infiltration and apoptotic cells are evident in these lesions [82, 89]. They are successfully treated with anti-TNF therapy [82], further emphasizing that proper control of TNFR-mediated signalling is critical for skin immunosurveillance. It is worth noting that keratinocyte SC niches are highly sensitive to TNF-mediated cell death in OTULIN-deficient conditions, causing autoinflammation and even carcinogenesis due to enhanced apoptotic and necroptotic responses in KCs [78, 87]. This is not the case in other high-turnover SC niches, such as the intestinal epithelium, where OTULIN deficiency does not cause spontaneous pathology [90].
Presence of apoptotic and necroptotic cells has been observed in patients suffering from a range of inflammatory skin diseases, including psoriasis, atopic dermatitis, vitiligo and epidermolysis bullosa [31, 91, 92]. In addition, genetic linkage studies have implicated apoptotic and necroptotic signalling pathways in various dermatological conditions. GWAS identified genetic variations in TNFAIP3 (encoding A20), TNIP1 and FASL, involved in apoptotic and necroptotic cell death regulation, as susceptibility factors for psoriasis vulgaris [93, 94]. In alopecia areata, a common hair loss disorder associated with autoinflammation, polymorphisms in the anti-apoptotic gene BCL2L2 have been identified [95]. Most importantly, TNF-neutralizing antibodies are highly successful for clinical treatment of moderate to severe psoriasis [96]. Skin samples from psoriatic patients show elevated levels of several necroptosis-associated proteins, such as RIPK1, RIPK3 and MLKL, and recent findings demonstrated that inhibiting KC necroptosis significantly delays the development of imiquimod-induced psoriasis in mice [91, 97]. Due to the fact that cell death and inflammation are so tightly linked, with cell death being a potential instigator or consequence of inflammation and vice versa, additional studies are needed to reveal which cell death mediators play a causative role in dermatitis. The first oral, selective RIPK1 inhibitor GSK2982772 is currently being tested for treatment of active plaque psoriasis patients, leading to reduced epidermal thickness and lower inflammatory infiltrates [98].
Pyroptosis
Pyroptosis is an inflammatory lytic cell death programme, characterized by rupture of the cell membrane due to gasdermin-mediated pore formation. Originally described as candidate genes causing hair loss [99], the mouse GSDM superfamily includes Gsdma (comprising 3 homologues), -c (comprising 4 homologues), -d and -e, while the human genome encodes for GSDM-A to -E and pejvakin. These proteins require cleavage to translocate and insert into the cell membrane [100,101,102]. While pyroptosis was initially believed to be a cell death programme exclusive to innate immunity cells like monocytes and macrophages, a surge in genetic evidence now suggests a crucial role for pyroptosis in KC and melanocyte biology [45]. Loss-of-function mutations in the human NLRP1 (Nod-like receptor family pyrin domain containing 1) gene, a pyroptotic receptor, are the causative factor for vitiligo-associated multiple autoimmune disease. These patients typically suffer from generalized vitiligo often associated with psoriasis or systemic lupus erythematosus [30]. Moreover, gain-of-function (GOF) mutations in NLRP1 have been identified in patients with dermatological conditions as a result of spontaneous inflammasome activation in KCs [103,104,105]. The importance of proper control of NLRP1 activity in skin is also apparent in patients carrying hypomorphic or knockout alleles of the NLRP1 inhibitor DPP9 (dipeptidyl peptidase 9), who present with skin pigmentation abnormalities [106]. Patients suffering from Cryopyrin-associated periodic syndrome (CAPS), due to GOF mutations in the inflammasome receptor NLRP3, present with severe cutaneous rashes [107]. Knockin of one such Nlrp3 mutation in mice phenocopies human CAPS, including severe dermatitis [108, 109]. It is important to stipulate that dysregulated inflammasome signalling can drive altered secretion of IL-1 and IL-18 by various cell-types and is not necessarily linked to enhanced cell death levels in KC compartments. However, mice carrying GOF mutations in mouse Nlrp3 are protected from dermatitis when crossed onto a GSDMD-deficient background, implicating a pivotal role for GSDMD-mediated pyroptosis in the skin [110]. Also, GSDME-mediated pyroptosis has been shown to protect keratinocytes from UV-radiation and viral infections [111, 112]. A third inflammasome receptor for which genetic variations have been linked to dermatological conditions is PYRIN (encoded by MEFV). These mutations recapitulate an immune response triggered by pathogens in skin and patients present with neutrophilic dermatosis, which can be ameliorated by blocking IL-1 signalling [113].
Whole-genome studies in psoriatic patients revealed SNPs (Single Nucleotide Polymorphisms) in AIM2, an activator of pyroptosis [114]. Intriguingly, AIM2 is crucial in establishing inflammatory memory in mouse EpdSCs, enabling them to respond more efficiently to subsequent insults [115]. KCs also express high levels of NLRP10 in the EpdSC niche upon differentiation, driving inflammasome formation in conditions of mitochondrial damage [46]. The role of this inflammasome in mediating cutaneous immunity is also apparent from the enhanced sensitivity of mice with keratinocyte-selective deletion of Nlrp10 to contact dermatitis [116]. Drugs targeting inflammasome activation or outcome, such as colchicine and Anakinra, are used to treat several inflammatory skin diseases, including neutrophilic dermatoses and hidradenitis suppurativa [117, 118]. Various clinical trials targeting IL-1 family cytokines to ameliorate dermatological conditions have been initiated and are reviewed elsewhere [119].
Ferroptosis
Ferroptosis is a cell death pathway that critically depends on iron radicals and peroxidation of plasma membrane lipids [120, 121]. Cells undergoing ferroptosis display shrinkage of their mitochondria with an increase in their membrane density and cristae reduction, but no cell shrinkage or swelling as seen in respectively apoptotic or necroptotic cells [121, 122]. Genetic deletion of Gpx4 (glutathione peroxidase 4), the main enzyme protecting cells from ferroptosis [120, 123], in KCs induces dysmorphic HFs, focal alopecia and dermatitis in mice. However, these phenotypes are transient in nature and mice lacking GPX4 in KCs have a normal lifespan [124]. So far, there is no in vivo proof directly linking ferroptotic cell death to inflammatory skin conditions. However, downregulation of GPX4 has been demonstrated in lesional skin of psoriatic patients, and treatment with the ferroptosis inhibitor ferrostatin-1 was shown to alleviate psoriasiform inflammation in mice [48]. Whether ferroptotic cell death is a cause or consequence of inflammation in these psoriatic plaques remains to be investigated.
Autophagy
Macro-autophagy (hereafter referred to as autophagy) is the major cellular machinery for the recycling of amino acids. While this programme serves as an important pro-survival mechanism, autophagy can also lead to cell death. Constitutive ablation of genes essential for autophagy results in embryonically lethal phenotypes, indicating the crucial role of this process in tissue development (reviewed in [125]). Impairment of key autophagy genes in KCs demonstrated a crucial role for this process in the terminal differentiation programme that is initiated in the EpdSC niche. Indeed, KC-selective ATG (autophagy-related gene) 7 or ATG16L1-deficient mice exhibit enhanced sensitivity to DNA damage, altered lipid composition and a thickened cornified layer, pointing to defects in the desquamation programme [25, 126, 127] (Table 1). A defective autophagic flux resulting from depletion of ATG16L1 in KCs, leads to precocious anagen induction due to enhanced cell death rates, indicating that the apoptotic death of KCs impacts on the activation kinetics of HFSCs [25]. Also ATG9A has recently been identified as a critical autophagy mediator for maintaining skin homeostasis. Removal of this factor from KCs results in substantial epidermal cell death and spontaneous dermatitis due to improper TNF detoxification, identifying a novel control mechanism preserving skin integrity [128].
Polymorphisms in human ATG16L1 have been linked to the dermatological conditions psoriasis vulgaris and palmoplantar pustulosis, further suggesting a role for keratinocyte autophagy in skin immunity [129, 130]. GWAS analyses of alopecia areata patients demonstrated associations with genes involved in autophagy, such as STX17 (Syntaxin 17) [95]. Together, these observations demonstrate that autophagy plays important roles in KCs, protecting them from TNF toxicity and safeguarding the molecular clock that regulates HFSC proliferation.
The impact of cell death on skin regeneration
Epithelial tissue repair depends on the activation of tissue-resident SCs [131]. Cell death responses are crucial in orchestrating the highly complex process of regeneration, eliminating immune cells recruited to the wound site and counterbalancing the accelerated epithelial proliferative state. Recent findings shed light on how cell death shapes the activation of SCs during regeneration. When skin is wounded, the epidermal barrier is breached and cytokines, chemokines and danger-associated molecular patterns (DAMPs) are released, inducing an immune response that assists in injury repair [5]. The first immune cells that infiltrate wounded skin in large numbers are neutrophils that are recruited by KCs secreting HMGB1 (high mobility group box-1), a prototypical DAMP [132]. These neutrophils can execute a specific cell death pathway involving the production of neutrophil extracellular traps (NETs), a process that is highly prominent in diabetic wounds. NETs serve as a bacterial defence mechanism, but are detrimental to cutaneous injury repair [47, 133]. Genetic and pharmacologic targeting of HMGB1 in mouse KCs suppresses NET formation and accelerates wound closure in normoglycemic and diabetic skin [132, 134]. Besides neutrophils, macrophages and dendritic cells infiltrate injured skin and contribute to healing not only by promoting inflammation, but also by acting as phagocytes removing dead cells through efferocytosis. These macrophages die by apoptosis during the skin repair process, hence, preventing apoptotic responses in this cell lineage significantly delays injury repair [135] (Fig. 4).
Activities of the effector caspases-3 and -7 are crucial for skin regeneration due to their capacities to eliminate damaged cells and release proliferative signals [136]. However, mice deficient for the pro-apoptotic protein ARTS exhibit accelerated cutaneous wound repair [137]. While apoptosis is paramount for skin regeneration, it is clear that proper control of apoptotic cell death rates determines the healing kinetics. This is also exemplified in a mouse model in which the crucial cell death regulator cFLIP can no longer be cleaved by caspase-8, resulting in exaggerated cell death and a significant delay in skin regeneration [138]. Not only do extrinsic apoptotic pathways mediate skin regeneration, but the deregulation of intrinsic apoptotic signalling in HFSCs can accelerate cutaneous wound responses [139]. Future research on other regulated cell death modalities and the mechanisms that keep them in check during tissue regeneration holds promise for novel therapeutic approaches in management of wound care.
Proper efferocytosis by macrophages and dendritic cells present in wounded skin is crucial for injury repair due to its anti-inflammatory effects [33, 140] (Fig. 4). Inhibition of efferocytosis receptors, such as AXL and TIMD4, delay the healing kinetics of murine wounds and upregulation of pathways mediating cell clearance has been shown in cutaneous mouse wounds and human diabetic wounds [141]. When apoptotic cell death rates surpass the phagocytic capacity of cells present in the microenvironment, secondary necrosis resulting in lytic cell death can occur [142]. While the mechanisms mediating efferocytosis have mainly been described in professional phagocytes, a role for KCs and fibroblasts as occasional phagocytes in skin is emerging. Indeed, phagocytosis of dying/dead cells by basal KCs of the HF has been described during the catagen stage of hair cycling and recent findings show that efferocytosis by HFSCs impacts their regenerative capacities [23, 143].
Cell death and skin tumour formation
While cytotoxic cancer therapies aim to kill tumour cells, cell death responses can induce proliferation of neighbouring stem cells [144] and even stimulate the repopulation of tumours undergoing radiotherapy [145]. In melanoma, cancer cells that escape apoptosis gain migratory and metastatic capacities [146]. So, while cell death is a crucial tumour-suppressive mechanism by removing (pre)malignant cells, it can also promote tumorigenesis by stimulating inflammatory, regenerative and even metastatic responses. Skin cancers also adhere to this duality. Overexpression of the anti-apoptotic protein BCL-XL sensitizes mouse KCs to carcinogenesis and malignancy [147]. Genetic alterations in KC survival pathways, for example those resulting in constitutive activation of AKT, accelerate skin tumour formation [148]. In carcinogenic conditions, TNF-mediated signalling pathways are crucial in determining the propensity of KCs to either proliferate or die. Mice deficient for both TNF receptors are resistant to chemically-induced skin cancer protocols [149]. Along these lines, NF-κB blockade by overexpression of the NFκB-inhibitor IκBα in human KCs promotes their transformation to squamous cell carcinomas (SCCs) and in mice, these conditions result in increased KC apoptosis and spontaneous SCC formation [150, 151]. A recent genetic screen identified several hits in the TNF signalling cascade sensitizing melanoma cells to elimination by T-cells, demonstrating the potential of manipulating cell death pathways in immune checkpoint blockade [152].
As is the case for apoptosis, necroptosis and pyroptosis can have either tumour-promoting or -suppressing effects in the skin, depending on the tumour type and stage. In various tumour types including malignant melanoma, necroptotic mediators are strongly suppressed, indicating acquired necroptotic resistance of tumour cells [153]. In line with this, senescent melanocytes that are capable of resisting cell death, are emerging as a potential cell-of-origin in melanoma and specific targeting of factors released by senescent melanocytes are showing promise in counteracting melanoma [154, 155]. In keratinocyte-derived tumours, such as head and neck SCC, a substantial amount of necroptosis has been reported and high levels of phosphorylated MLKL were shown to correlate with lymph node metastasis and tumour progression [156]. Intriguingly, naked mole-rats- a species known for its remarkable resistance to skin carcinogenesis- lack the necroptotic mediator RIPK3, suggesting a putative role for necroptosis in neoplastic skin responses [157]. This study also demonstrates that pharmacological or genetic inhibition of necroptosis delays chemically-induced skin carcinogenesis in mice [157]. However, more research is needed to elucidate whether, when and how specific cell death programmes should be targeted to enable more efficient and safer removal of tumour cells.
Conclusions
Collectively, the tight balance between keratinocyte proliferation and removal is crucial for the skin’s barrier function, but also for proper cycling of HFs. While periodic bouts of cell death are inherent to the HFSC niche, the abundant presence of dying cells in the EpdSC niche is detrimental to proper epidermal barrier function. While there is no doubt that apoptosis represents a crucial cell death modality important for skin homeostasis, hair cycling, and for counterbalancing tumour formation, a growing body of evidence points to important contributions of other regulated cell death programmes in these processes. The consequences of distinct cell death programmes on the survivor cells within specific SC niches are beginning to unravel as our understanding of the molecular executioners of these programmes increases. This allows us to pinpoint more precisely which types of cell death occur in the different SC compartments of the skin. However, our understanding of why certain progenitor cells are more sensitive to specific types of cell death has only recently begun to unfold. It remains unclear how this sensitivity is regulated and potentially altered in disease. Understanding these complex concepts holds the key to revealing the therapeutic potential of manipulating cell death programmes within the appropriate tissue context, thereby advancing clinical treatments of skin diseases.
Change history
02 September 2024
A Correction to this paper has been published: https://doi.org/10.1038/s41418-024-01362-x
References
Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the ‘epimmunome’. Nat Immunol. 2010;11:656–65. https://doi.org/10.1038/ni.1905
Hsu YC, Fuchs, E. Building and maintaining the skin. Cold Spring Harb Perspect Biol. 2022;14. https://doi.org/10.1101/cshperspect.a040840
Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature. 2005;437:275–80. https://doi.org/10.1038/nature03922
Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6:328–40. https://doi.org/10.1038/nrm1619
Naik S, Larsen SB, Cowley CJ, Fuchs E. Two to tango: dialog between immunity and stem cells in health and disease. Cell. 2018;175:908–20. https://doi.org/10.1016/j.cell.2018.08.071
Lippens S, Kockx M, Knaapen M, Mortier L, Polakowska R, Verheyen A, et al. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ. 2000;7:1218–24. https://doi.org/10.1038/sj.cdd.4400785
Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature. 2014;513:90–94. https://doi.org/10.1038/nature13608
Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA, Bloch W, et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity. 2011;35:572–82. https://doi.org/10.1016/j.immuni.2011.08.014
Kovalenko A, Kim JC, Kang TB, Rajput A, Bogdanov K, Dittrich-Breiholz O, et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med. 2009;206:2161–77. https://doi.org/10.1084/jem.20090616
Lee P, Lee DJ, Chan C, Chen SW, Ch’en I, Jamora C. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature. 2009;458:519–23. https://doi.org/10.1038/nature07687
Joost S, Annusver K, Jacob T, Sun X, Dalessandri T, Sivan U, et al. The molecular anatomy of mouse skin during hair growth and rest. Cell Stem Cell. 2020;26:441–57 e447. https://doi.org/10.1016/j.stem.2020.01.012
Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61:1329–37. https://doi.org/10.1016/0092-8674(90)90696-c
Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:635–48. https://doi.org/10.1016/j.cell.2004.08.012
Greco V, Chen T, Rendl M, Schober M, Pasolli HA, Stokes N, et al. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell. 2009;4:155–69. https://doi.org/10.1016/j.stem.2008.12.009
Donati G, Rognoni E, Hiratsuka T, Liakath-Ali K, Hoste E, Kar G, et al. Wounding induces dedifferentiation of epidermal Gata6(+) cells and acquisition of stem cell properties. Nat Cell Biol. 2017;19:603–13. https://doi.org/10.1038/ncb3532
Jensen KB, Collins CA, Nascimento E, Tan DW, Frye M, Itami S, et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell. 2009;4:427–39. https://doi.org/10.1016/j.stem.2009.04.014
Donati G, Watt FM. Stem cell heterogeneity and plasticity in epithelia. Cell Stem Cell. 2015;16:465–76. https://doi.org/10.1016/j.stem.2015.04.014
Ge Y, Fuchs E. Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer. Nat Rev Genet. 2018;19:311–25. https://doi.org/10.1038/nrg.2018.9
Sun, X, Joost, S, Kasper, M. Plasticity of epithelial cells during skin wound healing. Cold Spring Harb Perspect Biol. 2023;15. https://doi.org/10.1101/cshperspect.a041232
Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001;117:3–15. https://doi.org/10.1046/j.0022-202x.2001.01377.x
Jahoda CA, Horne KA, Oliver RF. Induction of hair growth by implantation of cultured dermal papilla cells. Nature. 1984;311:560–2. https://doi.org/10.1038/311560a0
Heitman N, Sennett R, Mok KW, Saxena N, Srivastava D, Martino P, et al. Dermal sheath contraction powers stem cell niche relocation during hair cycle regression. Science. 2020;367:161–6. https://doi.org/10.1126/science.aax9131
Mesa KR, Rompolas P, Zito G, Myung P, Sun TY, Brown S, et al. Niche-induced cell death and epithelial phagocytosis regulate hair follicle stem cell pool. Nature. 2015;522:94–97. https://doi.org/10.1038/nature14306
Tong X, Coulombe PA. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev. 2006;20:1353–64. https://doi.org/10.1101/gad.1387406
Van Hove L, Toniolo A, Ghiasloo M, Lecomte K, Boone F, Ciers M, et al. Autophagy critically controls skin inflammation and apoptosis-induced stem cell activation. Autophagy. 2023;19:2958–71. https://doi.org/10.1080/15548627.2023.2247742
Xie Y, Chen D, Jiang K, Song L, Qian N, Du Y, et al. Hair shaft miniaturization causes stem cell depletion through mechanosensory signals mediated by a Piezo1-calcium-TNF-alpha axis. Cell Stem Cell. 2022;29:70–85 e76. https://doi.org/10.1016/j.stem.2021.09.009
Castellana D, Paus R, Perez-Moreno M. Macrophages contribute to the cyclic activation of adult hair follicle stem cells. PLoS Biol. 2014;12:e1002002 https://doi.org/10.1371/journal.pbio.1002002
Lu CP, Polak L, Rocha AS, Pasolli HA, Chen SC, Sharma N, et al. Identification of stem cell populations in sweat glands and ducts reveals roles in homeostasis and wound repair. Cell. 2012;150:136–50. https://doi.org/10.1016/j.cell.2012.04.045
Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44:676–80. https://doi.org/10.1038/ng.2272
Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356:1216–25. https://doi.org/10.1056/NEJMoa061592
Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W. Cell death in the skin. Apoptosis. 2009;14:549–69. https://doi.org/10.1007/s10495-009-0324-z
Sengupta A, Lichti UF, Carlson BA, Ryscavage AO, Gladyshev VN, Yuspa SH, et al. Selenoproteins are essential for proper keratinocyte function and skin development. PLoS ONE. 2010;5:e12249 https://doi.org/10.1371/journal.pone.0012249
Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov. 2022;21:601–20. https://doi.org/10.1038/s41573-022-00470-y
Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517:311–20. https://doi.org/10.1038/nature14191
Newton K, Dixit VM, Kayagaki N. Dying cells fan the flames of inflammation. Science. 2021;374:1076–80. https://doi.org/10.1126/science.abi5934
Lasry A, Ben-Neriah Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 2015;36:217–28. https://doi.org/10.1016/j.it.2015.02.009
Upton JW, Kaiser WJ, Mocarski ES. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe. 2019;26:564 https://doi.org/10.1016/j.chom.2019.09.004
He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 2009;137:1100–11. https://doi.org/10.1016/j.cell.2009.05.021
Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M, et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci USA. 2013;110:E3109–18. https://doi.org/10.1073/pnas.1301218110
Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489–95. https://doi.org/10.1038/82732
Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell. 2011;43:449–63. https://doi.org/10.1016/j.molcel.2011.06.011
Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol. 2014;16:55–65. https://doi.org/10.1038/ncb2883
Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666–71. https://doi.org/10.1038/nature15541
Kayagaki N, Kornfeld OS, Lee BL, Stowe IB, O’Rourke K, Li Q, et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature. 2021;591:131–6. https://doi.org/10.1038/s41586-021-03218-7
Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2023. https://doi.org/10.1038/s41573-023-00822-2
Prochnicki T, Vasconcelos MB, Robinson KS, Mangan MSJ, De Graaf D, Shkarina K, et al. Mitochondrial damage activates the NLRP10 inflammasome. Nat Immunol. 2023;24:595–603. https://doi.org/10.1038/s41590-023-01451-y
Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med. 2015;21:815–9. https://doi.org/10.1038/nm.3887
Shou Y, Yang L, Yang Y, Xu J. Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis. 2021;12:1009 https://doi.org/10.1038/s41419-021-04284-5
Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378 https://doi.org/10.1038/s41392-022-01229-y
Hedgecock EM, Sulston JE, Thomson JN. Mutations affecting programmed cell deaths in the nematode Caenorhabditis elegans. Science. 1983;220:1277–9. https://doi.org/10.1126/science.6857247
Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147:742–58. https://doi.org/10.1016/j.cell.2011.10.033
Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell. 2000;6:1389–99. https://doi.org/10.1016/s1097-2765(00)00136-2
Medina CB, Mehrotra P, Arandjelovic S, Perry JSA, Guo Y, Morioka S, et al. Metabolites released from apoptotic cells act as tissue messengers. Nature. 2020;580:130–5. https://doi.org/10.1038/s41586-020-2121-3
Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. https://doi.org/10.1016/s0074-7696(08)62312-8
Fadok VA, Bratton DL, Guthrie L, Henson PM. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol. 2001;166:6847–54. https://doi.org/10.4049/jimmunol.166.11.6847
Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP, et al. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell. 2009;36:487–99. https://doi.org/10.1016/j.molcel.2009.09.030
Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–57. https://doi.org/10.1016/s0092-8674(00)80085-9
Sotiropoulou PA, Candi A, Mascre G, De Clercq S, Youssef KK, Lapouge G, et al. Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol. 2010;12:572–82. https://doi.org/10.1038/ncb2059
Geueke A, Mantellato G, Kuester F, Schettina P, Nelles M, Seeger JM, et al. The anti-apoptotic Bcl-2 protein regulates hair follicle stem cell function. EMBO Rep. 2021;22:e52301 https://doi.org/10.15252/embr.202052301
Yusupova M, Ankawa R, Yosefzon Y, Meiri D, Bachelet I, Fuchs Y. Apoptotic dysregulation mediates stem cell competition and tissue regeneration. Nat Commun. 2023;14:7547 https://doi.org/10.1038/s41467-023-41684-x
van Loo G, Bertrand MJM. Death by TNF: a road to inflammation. Nat Rev Immunol. 2023;23:289–303. https://doi.org/10.1038/s41577-022-00792-3
Newton K, Wickliffe KE, Dugger DL, Maltzman A, Roose-Girma M, Dohse M, et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature. 2019;574:428–31. https://doi.org/10.1038/s41586-019-1548-x
Chen KW, Demarco B, Heilig R, Shkarina K, Boettcher A, Farady CJ, et al. Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 2019;38. https://doi.org/10.15252/embj.2019101638
Newton K, Wickliffe KE, Maltzman A, Dugger DL, Reja R, Zhang Y, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575:679–82. https://doi.org/10.1038/s41586-019-1752-8
Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature. 2002;417:861–866. https://doi.org/10.1038/nature00820
Panayotova-Dimitrova D, Feoktistova M, Ploesser M, Kellert B, Hupe M, Horn S, et al. cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep. 2013;5:397–408. https://doi.org/10.1016/j.celrep.2013.09.035
Weinlich R, Oberst A, Dillon CP, Janke LJ, Milasta S, Lukens JR, et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep. 2013;5:340–348. https://doi.org/10.1016/j.celrep.2013.08.045
Grinberg-Bleyer Y, Dainichi T, Oh H, Heise N, Klein U, Schmid RM, et al. Cutting edge: NF-kappaB p65 and c-Rel control epidermal development and immune homeostasis in the skin. J Immunol. 2015;194:2472–2476. https://doi.org/10.4049/jimmunol.1402608
Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, Smart RC, et al. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem. 2006;281:19610–17. https://doi.org/10.1074/jbc.M603384200
Nenci A, Huth M, Funteh A, Schmidt-Supprian M, Bloch W, Metzger D, et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum Mol Genet. 2006;15:531–42. https://doi.org/10.1093/hmg/ddi470
Gareus R, Huth M, Breiden B, Nenci A, Rosch N, Haase I, et al. Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol. 2007;9:461–9. https://doi.org/10.1038/ncb1560
Lippens S, Lefebvre S, Gilbert B, Sze M, Devos M, Verhelst K, et al. Keratinocyte-specific ablation of the NF-kappaB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ. 2011;18:1845–53. https://doi.org/10.1038/cdd.2011.55
Etemadi N, Chopin M, Anderton H, Tanzer MC, Rickard JA, Abeysekera W, et al. TRAF2 regulates TNF and NF-kappaB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1. Elife. 2015;4. https://doi.org/10.7554/eLife.10592
Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A, et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet. 2002;11:2371–5. https://doi.org/10.1093/hmg/11.20.2371
Newton K, Wickliffe KE, Maltzman A, Dugger DL, Strasser A, Pham VC, et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature. 2016;540:129–33. https://doi.org/10.1038/nature20559
Lin J, Kumari S, Kim C, Van TM, Wachsmuth L, Polykratis A, et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature. 2016;540:124–8. https://doi.org/10.1038/nature20558
Devos M, Tanghe G, Gilbert B, Dierick E, Verheirstraeten M, Nemegeer J, et al. Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation. J Exp Med. 2020;217. https://doi.org/10.1084/jem.20191913
Hoste E, Lecomte K, Annusver K, Vandamme N, Roels J, Maschalidi S, et al. OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity. Nat Commun. 2021;12:5913. https://doi.org/10.1038/s41467-021-25944-2
Taraborrelli L, Peltzer N, Montinaro A, Kupka S, Rieser E, Hartwig T, et al. LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L. Nat Commun. 2018;9:3910 https://doi.org/10.1038/s41467-018-06155-8
Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591–605. https://doi.org/10.1038/s41418-020-00708-5
Peltzer N, Darding M, Montinaro A, Draber P, Draberova H, Kupka S, et al. LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. Nature. 2018;557:112–7. https://doi.org/10.1038/s41586-018-0064-8
Damgaard RB, Walker JA, Marco-Casanova P, Morgan NV, Titheradge HL, Elliott PR, et al. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell. 2016;166:1215–30 e1220. https://doi.org/10.1016/j.cell.2016.07.019
Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, Barford D. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 2009;10:466–73. https://doi.org/10.1038/embor.2009.55
Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 2011;471:591–6. https://doi.org/10.1038/nature09816
Keusekotten K, Elliott PR, Glockner L, Fiil BK, Damgaard RB, Kulathu Y, et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell. 2013;153:1312–26. https://doi.org/10.1016/j.cell.2013.05.014
HogenEsch H, Gijbels MJ, Offerman E, van Hooft J, van Bekkum DW, Zurcher C. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol. 1993;143:972–82.
Schunke H, Gobel U, Dikic I, Pasparakis M. OTULIN inhibits RIPK1-mediated keratinocyte necroptosis to prevent skin inflammation in mice. Nat Commun. 2021;12:5912 https://doi.org/10.1038/s41467-021-25945-1
Sundberg JP, Pratt CH, Goodwin LP, Silva KA, Kennedy VE, Potter CS, et al. Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice. PLoS ONE. 2020;15:e0235295 https://doi.org/10.1371/journal.pone.0235295
Damgaard RB, Elliott PR, Swatek KN, Maher ER, Stepensky P, Elpeleg O, et al. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol Med. 2019;11. https://doi.org/10.15252/emmm.201809324
Verboom L, Anderson CJ, Jans M, Petta I, Blancke G, Martens A, et al. OTULIN protects the intestinal epithelium from apoptosis during inflammation and infection. Cell Death Dis. 2023;14:534 https://doi.org/10.1038/s41419-023-06058-7
Duan X, Liu X, Liu N, Huang Y, Jin Z, Zhang S, et al. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation. Cell Death Dis. 2020;11:134 https://doi.org/10.1038/s41419-020-2328-0
Zhang K, Anumanthan G, Scheaffer S, Cornelius LA. HMGB1/RAGE mediates UVB-induced secretory inflammatory response and resistance to apoptosis in human melanocytes. J Investig Dermatol. 2019;139:202–12. https://doi.org/10.1016/j.jid.2018.05.035
Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199–204. https://doi.org/10.1038/ng.311
Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;8:15382 https://doi.org/10.1038/ncomms15382
Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, et al. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015;6:5966 https://doi.org/10.1038/ncomms6966
Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356:385–90. https://doi.org/10.1016/S0140-6736(00)02530-7
Honda T, Yamamoto O, Sawada Y, Egawa G, Kitoh A, Otsuka A, et al. Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis-independent manner and promotes psoriatic dermatitis in mice. J Allergy Clin Immunol. 2017;140:619–22 e616. https://doi.org/10.1016/j.jaci.2017.02.027
Weisel K, Berger S, Papp K, Maari C, Krueger JG, Scott N, et al. Response to inhibition of receptor-interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo-controlled study. Clin Pharmacol Ther. 2020;108:808–16. https://doi.org/10.1002/cpt.1852
Sato H, Koide T, Masuya H, Wakana S, Sagai T, Umezawa A, et al. A new mutation Rim3 resembling Re(den) is mapped close to retinoic acid receptor alpha (Rara) gene on mouse chromosome 11. Mamm Genome. 1998;9:20–25. https://doi.org/10.1007/s003359900673
Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111–6. https://doi.org/10.1038/nature18590
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153–8. https://doi.org/10.1038/nature18629
Aglietti RA, Estevez A, Gupta A, Ramirez MG, Liu PS, Kayagaki N, et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA. 2016;113:7858–63. https://doi.org/10.1073/pnas.1607769113
Zhong FL, Mamai O, Sborgi L, Boussofara L, Hopkins R, Robinson K, et al. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell. 2016;167:187–202 e117. https://doi.org/10.1016/j.cell.2016.09.001
Drutman SB, Haerynck F, Zhong FL, Hum D, Hernandez NJ, Belkaya S, et al. Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis. Proc Natl Acad Sci USA. 2019;116:19055–63. https://doi.org/10.1073/pnas.1906184116
Mamai O, Boussofara L, Denguezli M, Escande-Beillard N, Kraeim W, Merriman B, et al. Multiple self-healing palmoplantar carcinoma: a familial predisposition to skin cancer with primary palmoplantar and conjunctival lesions. J Invest Dermatol. 2015;135:304–8. https://doi.org/10.1038/jid.2014.311
Harapas CR, Robinson KS, Lay K, Wong J, Moreno Traspas R, Nabavizadeh N, et al. DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling. Sci Immunol. 2022;7:eabi4611 https://doi.org/10.1126/sciimmunol.abi4611
Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301–5. https://doi.org/10.1038/ng756
Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, Gandhi C, et al. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity. 2009;30:875–87. https://doi.org/10.1016/j.immuni.2009.05.005
Meng G, Zhang F, Fuss I, Kitani A, Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity. 2009;30:860–74. https://doi.org/10.1016/j.immuni.2009.04.012
Xiao J, Wang C, Yao JC, Alippe Y, Xu C, Kress D, et al. Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice. PLoS Biol. 2018;16:e3000047 https://doi.org/10.1371/journal.pbio.3000047
Chen Y, Lian N, Chen S, Xiao T, Ke Y, Zhang Y, et al. GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils. Cell Death Dis. 2022;13:841 https://doi.org/10.1038/s41419-022-05276-9
Orzalli MH, Prochera A, Payne L, Smith A, Garlick JA, Kagan JC. Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. Immunity. 2021;54:1447–62 e1445. https://doi.org/10.1016/j.immuni.2021.04.012
Masters SL, Lagou V, Jeru I, Baker PJ, Van Eyck L, Parry DA, et al. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci Transl Med. 2016;8:332ra345 https://doi.org/10.1126/scitranslmed.aaf1471
Zuo X, Sun L, Yin X, Gao J, Sheng Y, Xu J, et al. Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nat Commun. 2015;6:6793 https://doi.org/10.1038/ncomms7793
Naik S, Larsen SB, Gomez NC, Alaverdyan K, Sendoel A, Yuan S, et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017;550:475–80. https://doi.org/10.1038/nature24271
Damm A, Giebeler N, Zamek J, Zigrino P, Kufer TA. Epidermal NLRP10 contributes to contact hypersensitivity responses in mice. Eur J Immunol. 2016;46:1959–69. https://doi.org/10.1002/eji.201646401
Koska MC, Karadag AS, Durdu M. Annular neutrophilic dermatoses. Clin Dermatol. 2023;41:340–54. https://doi.org/10.1016/j.clindermatol.2023.07.003
Zarchi K, Dufour DN, Jemec GB. Successful treatment of severe hidradenitis suppurativa with anakinra. JAMA Dermatol. 2013;149:1192–4. https://doi.org/10.1001/jamadermatol.2013.5377
Calabrese L, Fiocco Z, Satoh TK, Peris K, French LE. Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases. Br J Dermatol. 2022;186:925–41. https://doi.org/10.1111/bjd.20975
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266–82. https://doi.org/10.1038/s41580-020-00324-8
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72. https://doi.org/10.1016/j.cell.2012.03.042
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88 https://doi.org/10.1038/s41419-020-2298-2
Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8:237–48. https://doi.org/10.1016/j.cmet.2008.07.005
Sengupta A, Lichti UF, Carlson BA, Cataisson C, Ryscavage AO, Mikulec C, et al. Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2. J Investig Dermatol. 2013;133:1731–41. https://doi.org/10.1038/jid.2013.52
Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349–64. https://doi.org/10.1038/s41580-018-0003-4
Rossiter H, Konig U, Barresi C, Buchberger M, Ghannadan M, Zhang CF, et al. Epidermal keratinocytes form a functional skin barrier in the absence of Atg7 dependent autophagy. J Dermatol Sci. 2013;71:67–75. https://doi.org/10.1016/j.jdermsci.2013.04.015
Song X, Narzt MS, Nagelreiter IM, Hohensinner P, Terlecki-Zaniewicz L, Tschachler E, et al. Autophagy deficient keratinocytes display increased DNA damage, senescence and aberrant lipid composition after oxidative stress in vitro and in vivo. Redox Biol. 2017;11:219–30. https://doi.org/10.1016/j.redox.2016.12.015
Huyghe J, Priem D, Van Hove L, Gilbert B, Fritsch J, Uchiyama Y, et al. ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway. Science. 2022;378:1201–7. https://doi.org/10.1126/science.add6967
Douroudis K, Kingo K, Traks T, Ratsep R, Silm H, Vasar E, et al. ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Hum Immunol. 2011;72:613–5. https://doi.org/10.1016/j.humimm.2011.03.009
Douroudis K, Kingo K, Traks T, Reimann E, Raud K, Ratsep R, et al. Polymorphisms in the ATG16L1 gene are associated with psoriasis vulgaris. Acta Derm Venereol. 2012;92:85–87. https://doi.org/10.2340/00015555-1183
Arwert EN, Hoste E, Watt FM. Epithelial stem cells, wound healing and cancer. Nat Rev Cancer. 2012;12:170–80. https://doi.org/10.1038/nrc3217
Hoste E, Maueroder C, van Hove L, Catrysse L, Vikkula HK, Sze M, et al. Epithelial HMGB1 delays skin wound healing and drives tumor initiation by priming neutrophils for NET formation. Cell Rep. 2019;29:2689–701 e2684. https://doi.org/10.1016/j.celrep.2019.10.104
Menegazzo L, Ciciliot S, Poncina N, Mazzucato M, Persano M, Bonora B, et al. NETosis is induced by high glucose and associated with type 2 diabetes. Acta Diabetol. 2015;52:497–503. https://doi.org/10.1007/s00592-014-0676-x
Mees MA, Boone F, Bouwen T, Vanaerschot F, Titeca C, Vikkula HK, et al. Glycyrrhizin-based hydrogels accelerate wound healing of normoglycemic and diabetic mouse skin. Pharmaceutics. 2022;15. https://doi.org/10.3390/pharmaceutics15010027
Injarabian L, Willenborg S, Welcker D, Sanin DE, Pasparakis M, Kashkar H, et al. FADD- and RIPK3-mediated cell death ensures clearance of Ly6C(high) wound macrophages from damaged tissue. J Investig Dermatol. 2023. https://doi.org/10.1016/j.jid.2023.06.203
Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS, et al. Apoptotic cells activate the “phoenix rising” pathway to promote wound healing and tissue regeneration. Sci Signal. 2010;3:ra13 https://doi.org/10.1126/scisignal.2000634
Fuchs Y, Brown S, Gorenc T, Rodriguez J, Fuchs E, Steller H. Sept4/ARTS regulates stem cell apoptosis and skin regeneration. Science. 2013;341:286–9. https://doi.org/10.1126/science.1233029
Martinez Lagunas K, Savcigil DP, Zrilic M, Carvajal Fraile C, Craxton A, Self E, et al. Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair. Sci Adv. 2023;9:eadg2829 https://doi.org/10.1126/sciadv.adg2829
Ankawa R, Goldberger N, Yosefzon Y, Koren E, Yusupova M, Rosner D, et al. Apoptotic cells represent a dynamic stem cell niche governing proliferation and tissue regeneration. Dev Cell. 2021;56:1900–16.e1905. https://doi.org/10.1016/j.devcel.2021.06.008
Maschalidi S, Mehrotra P, Keceli BN, De Cleene HKL, Lecomte K, Van der Cruyssen R, et al. Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes. Nature. 2022;606:776–84. https://doi.org/10.1038/s41586-022-04754-6
Justynski O, Bridges K, Krause W, Forni MF, Phan QM, Sandoval-Schaefer T, et al. Apoptosis recognition receptors regulate skin tissue repair in mice. Elife. 2023;12. https://doi.org/10.7554/eLife.86269
Silva MT. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett. 2010;584:4491–9. https://doi.org/10.1016/j.febslet.2010.10.046
Stewart KS, Gonzales KA, Yuan S, Tierney MT, Bonny AR, Yang Y, et al. Stem cells tightly regulate dead cell clearance to maintain tissue fitness. bioRxiv. 2023. https://doi.org/10.1101/2023.05.22.541773
Brock CK, Wallin ST, Ruiz OE, Samms KM, Mandal A, Sumner EA, et al. Stem cell proliferation is induced by apoptotic bodies from dying cells during epithelial tissue maintenance. Nat Commun. 2019;10:1044 https://doi.org/10.1038/s41467-019-09010-6
Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011;17:860–6. https://doi.org/10.1038/nm.2385
Berthenet K, Castillo Ferrer C, Fanfone D, Popgeorgiev N, Neves D, Bertolino P, et al. Failed apoptosis enhances melanoma cancer cell aggressiveness. Cell Rep. 2020;31:107731 https://doi.org/10.1016/j.celrep.2020.107731
Pena JC, Rudin CM, Thompson CB. A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res. 1998;58:2111–6.
Suzuki A, Itami S, Ohishi M, Hamada K, Inoue T, Komazawa N, et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 2003;63:674–81.
Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene. 2004;23:1902–10. https://doi.org/10.1038/sj.onc.1207317
van Hogerlinden M, Rozell BL, Ahrlund-Richter L, Toftgard R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 1999;59:3299–303.
Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 2003;421:639–43. https://doi.org/10.1038/nature01283
Vredevoogd DW, Kuilman T, Ligtenberg MA, Boshuizen J, Stecker KE, de Bruijn B, et al. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold. Cell. 2019;178:585–99.e515. https://doi.org/10.1016/j.cell.2019.06.014
Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, et al. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis. 2015;6:e1884 https://doi.org/10.1038/cddis.2015.240
Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619–36. https://doi.org/10.1038/s41571-022-00668-4
Liu J, Zheng R, Zhang Y, Jia S, He Y, Liu J. The cross talk between cellular senescence and melanoma: from molecular pathogenesis to target therapies. Cancers. 2023;15. https://doi.org/10.3390/cancers15092640
Li J, Huang S, Zeng L, Li K, Yang L, Gao S, et al. Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model. Cell Death Dis. 2020;11:391 https://doi.org/10.1038/s41419-020-2538-5
Oka K, Fujioka S, Kawamura Y, Komohara Y, Chujo T, Sekiguchi K, et al. Resistance to chemical carcinogenesis induction via a dampened inflammatory response in naked mole-rats. Commun Biol. 2022;5:287 https://doi.org/10.1038/s42003-022-03241-y
Hsu YC, Pasolli HA, Fuchs E. Dynamics between stem cells, niche, and progeny in the hair follicle. Cell. 2011;144:92–105. https://doi.org/10.1016/j.cell.2010.11.049
Acknowledgements
We apologize to the authors whose work we could not discuss due to space limitations. We thank Geert van Loo for critical reading of the manuscript. KL is supported by an FWO research project (3G032320), AT is supported by a ‘Stichting tegen Kanker’ research project (365L04523). Work in the lab of EH is funded by a Leo Foundation Award Region EMEA, the Special Research Fund of Ghent University (BOF/24J/2023/138) and FWO (Research grant 3G032320). Figures were created using Inkscape and Biorender.
Author information
Authors and Affiliations
Contributions
KL wrote the manuscript and designed figures. AT wrote the manuscript and designed figures. EH conceptualized, wrote and revised the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The authors Kim Lecomte and Annagiada Toniolo have contributed equally to this work. Although Kim Lecomte and Annagiada Toniolo were indicated as co-first authors.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lecomte, K., Toniolo, A. & Hoste, E. Cell death as an architect of adult skin stem cell niches. Cell Death Differ 31, 957–969 (2024). https://doi.org/10.1038/s41418-024-01297-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41418-024-01297-3
- Springer Nature Limited